fingolimod hydrochloride has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrd, JC; Jarjoura, D; Lee, LJ; Lee, RJ; Mao, Y; Mo, X; Muthusamy, N; Paulaitis, ME; Wang, X; Yu, B; Yuan, Y; Yue, C | 1 |
| Andritsos, L; Baskar, S; Byrd, JC; Chen, CS; Chiang, CL; Flynn, J; Frissora, FW; Jones, J; Lee, LJ; Lee, RJ; Mani, R; Mao, Y; Mo, X; Muthusamy, N; Phelps, MA; Rader, C; Wang, J; Wu, Y; Yan, R; Yu, B; Yu, L; Zhao, Y | 1 |
| Bordin, L; Brunati, AM; Facco, M; Frezzato, F; Pagano, MA; Pavan, V; Ribaudo, G; Semenzato, G; Tibaldi, E; Trentin, L; Trimarco, V; Zagotto, G; Zonta, F | 1 |
| Byrd, JC; Chen, CS; Dalton, JT; Frissora, F; Jarjoura, D; Lehman, A; Liu, Q; Ma, Y; Muthusamy, N; Perrotti, D; Santhanam, R; Zhao, X | 1 |
4 other study(ies) available for fingolimod hydrochloride and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.
Topics: Antibodies, Monoclonal; Antigens, CD19; Antigens, CD20; Antigens, Neoplasm; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Drug Delivery Systems; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Propylene Glycols; Sphingosine; Tetraspanins | 2013 |
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia.
Topics: Animals; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Lymphoma, Mantle-Cell; Mice; Mice, Transgenic; Nanoparticles; Oligonucleotide Array Sequence Analysis; Phosphorylation; Propylene Glycols; Protein Kinase C; Receptor Tyrosine Kinase-like Orphan Receptors; Sphingosine; Treatment Outcome | 2015 |
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.
Topics: Apoptosis; DNA-Binding Proteins; Fingolimod Hydrochloride; Histone Chaperones; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Phosphotyrosine; Propylene Glycols; Protein Interaction Maps; Protein Phosphatase 2; Signal Transduction; Sphingosine; src-Family Kinases; Transcription Factors; Tumor Cells, Cultured | 2015 |
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
Topics: Animals; Apoptosis; B-Lymphocytes; Caspases; Cell Line; Cysteine Endopeptidases; Down-Regulation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lysophospholipids; Mice; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propylene Glycols; Protein Phosphatase 2; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sphingosine; Xenograft Model Antitumor Assays | 2008 |